Clinical Trial Optimization: Key Strategies for Protocol Feasibility and Site Selection
Clinical trials are the cornerstone of medical advancements, playing a pivotal role in the development of new treatments, interventions and understanding of diseases. Optimizing their success is crucial and real-world data (RWD) is increasingly recognized as a way to...
TriNetX Achieves Spain’s ENS Certification for Rigorous Healthcare Data Security Standards
Company recognized with high-level certification for abiding by Spain’s strongest data security measures, sets a new standard for healthcare data protection within its TriNetX LIVE™ platform. Cambridge, MA, September 18, 2024 — TriNetX®, a leader in...
The Future of Oncology Research in Europe: Integrating Real-World Evidence into Joint Clinical Assessments
The global healthcare landscape is rapidly evolving, driven by advancements in technology, changes in regulatory frameworks, and an increased focus on patient-centered care. One of the pivotal developments in recent years is the concept of Joint Clinical Assessment...
Network Spotlight: The MetroHealth System
We are honored to recognize MetroHealth for their partnership with TriNetX. From increasing its clinical research opportunities to publishing more than 65 peer-reviewed manuscripts, The MetroHealth System – a nonprofit, public health system dedicated to hope, health,...
From Informative to Transformative: How Real-World Data is Fueling Healthcare Innovation
In 2024, the volume of healthcare real-world data (RWD) continues to grow exponentially. Healthcare generates around 30 percent of the world’s total data volume, and this growth is largely driven by advancements in RWD sources, including electronic health...
Equity in Action: Data-Driven Strategies to Advance Diversity in Clinical Trials
“Diversity in clinical trials” is undoubtedly one of the hottest topics in the healthcare industry today and with good reason. Underrepresentation in clinical trials can have significant and wide-ranging consequences — impacting the quality and applicability of...
Harnessing Real-World Data to Revolutionize Chronic Lymphocytic Leukemia Research
Chronic Lymphocytic Leukemia (CLL), a type of slow-growing cancer of the blood and bone marrow, accounts for 25-30 percent of all leukemia in the Western world and is the most common type of leukemia in adults, with over 100,000 new global incidence cases and over...
Real-World Data and Real-World Evidence: Shaping Global Regulatory Practices
This infographic blog post is derived from the recent article by Jeffrey Brown, PhD, The Role of RWD and RWE in Shaping Global Regulatory Practices, published in the June 2024 issue of DIA Global Forum. Download the Infographic Summary Courtesy of TriNetX Experts...